Document is current
Any future updates will be listed below
-
Authors
Hegyi, Thomas
Huber, Andrew
Oh, William
Kleinfeld, Alan
- License Information
-
More Information
Article History
Received: 28 June 2025
Revised: 13 October 2025
Accepted: 21 October 2025
First Online: 2 December 2025
Competing interests
: A.K. is the CEO of Fluoresprobe, Inc. Patient consent was not required for this study.
